{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:48:25Z","timestamp":1787021305343,"version":"build-2736575974"},"reference-count":35,"publisher":"The Endocrine Society","issue":"7","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK089216"],"award-info":[{"award-number":["R01DK089216"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30DK056341"],"award-info":[{"award-number":["P30DK056341"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32DK007161-43"],"award-info":[{"award-number":["5T32DK007161-43"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010511","name":"Clinical and Translational Science Institute, University of California, San Francisco","doi-asserted-by":"publisher","award":["NCATS\u2013UL1-TR00004"],"award-info":[{"award-number":["NCATS\u2013UL1-TR00004"]}],"id":[{"id":"10.13039\/100010511","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Marc Benioff"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"DOI":"10.1210\/jc.2018-02772","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T09:31:56Z","timestamp":1552555916000},"page":"3003-3011","source":"Crossref","is-referenced-by-count":26,"title":["Isocaloric Fructose Restriction Reduces Serum d-Lactate Concentration in Children With Obesity and Metabolic Syndrome"],"prefix":"10.1210","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1580-9163","authenticated-orcid":false,"given":"Ayca","family":"Erkin-Cakmak","sequence":"first","affiliation":[{"name":"Division of Pediatric Endocrinology, Department of Pediatrics, University of California San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Bains","sequence":"additional","affiliation":[{"name":"Glycation, Oxidation and Disease Laboratory, Department of Research, Touro University California College of Osteopathic Medicine, Vallejo, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Caccavello","sequence":"additional","affiliation":[{"name":"Glycation, Oxidation and Disease Laboratory, Department of Research, Touro University California College of Osteopathic Medicine, Vallejo, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan M","family":"Noworolski","sequence":"additional","affiliation":[{"name":"Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Schwarz","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, University of California San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Mulligan","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Department of Medicine, University of California San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H","family":"Lustig","sequence":"additional","affiliation":[{"name":"Division of Pediatric Endocrinology, Department of Pediatrics, University of California San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Gugliucci","sequence":"additional","affiliation":[{"name":"Glycation, Oxidation and Disease Laboratory, Department of Research, Touro University California College of Osteopathic Medicine, Vallejo, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2019,3,14]]},"reference":[{"key":"2019060606052398700_bib1","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.cmet.2018.02.003","article-title":"Elevated levels of the reactive metabolite methylglyoxal recapitulate progression of type 2 diabetes","volume":"27","author":"Moraru","year":"2018","journal-title":"Cell Metab"},{"issue":"7","key":"2019060606052398700_bib2","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology"},{"issue":"1","key":"2019060606052398700_bib3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.29721","article-title":"Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis","volume":"68","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"2019060606052398700_bib4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"2019060606052398700_bib5","first-page":"216","article-title":"Non-alcoholic fatty liver disease in lean subjects: characteristics and implications","volume":"5","author":"Kumar","year":"2017","journal-title":"J Clin Transl Hepatol"},{"issue":"3","key":"2019060606052398700_bib6","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1210\/jc.2015-3444","article-title":"Body mass index and risk of nonalcoholic fatty liver disease: two electronic health record prospective studies","volume":"101","author":"Loomis","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2019060606052398700_bib7","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1542\/peds.2006-1212","article-title":"Prevalence of fatty liver in children and adolescents","volume":"118","author":"Schwimmer","year":"2006","journal-title":"Pediatrics"},{"issue":"5","key":"2019060606052398700_bib8","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1007\/s10620-016-4054-0","article-title":"Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease","volume":"61","author":"Softic","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"5","key":"2019060606052398700_bib9","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"issue":"3","key":"2019060606052398700_bib10","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"issue":"3","key":"2019060606052398700_bib11","first-page":"167","article-title":"Pathogenesis and prevention of hepatic steatosis","volume":"11","author":"Nassir","year":"2015","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"5","key":"2019060606052398700_bib12","doi-asserted-by":"crossref","first-page":"754S","DOI":"10.1093\/ajcn\/58.5.754S","article-title":"Intermediary metabolism of fructose","volume":"58","author":"Mayes","year":"1993","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"2019060606052398700_bib13","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jhep.2008.02.011","article-title":"Fructose consumption as a risk factor for non-alcoholic fatty liver disease","volume":"48","author":"Ouyang","year":"2008","journal-title":"J Hepatol"},{"issue":"9","key":"2019060606052398700_bib14","doi-asserted-by":"crossref","first-page":"E981","DOI":"10.3390\/nu9090981","article-title":"Fructose consumption, lipogenesis, and non-alcoholic fatty liver disease","volume":"9","author":"Ter Horst","year":"2017","journal-title":"Nutrients"},{"issue":"3","key":"2019060606052398700_bib15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.cmet.2018.08.014","article-title":"The role of advanced glycation end products in aging and metabolic diseases: bridging association and causality","volume":"28","author":"Chaudhuri","year":"2018","journal-title":"Cell Metab"},{"issue":"1","key":"2019060606052398700_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1743-7075-10-32","article-title":"Fructose-induced stress signaling in the liver involves methylglyoxal","volume":"10","author":"Wei","year":"2013","journal-title":"Nutr Metab (Lond)"},{"issue":"5","key":"2019060606052398700_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrgastro.2010.41","article-title":"The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome","volume":"7","author":"Lim","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"2019060606052398700_bib18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0098-2997(93)90002-U","article-title":"The glyoxalase system in health and disease","volume":"14","author":"Thornalley","year":"1993","journal-title":"Mol Aspects Med"},{"key":"2019060606052398700_bib19","article-title":"Glyoxalase 1 modulation in obesity and diabetes [published online ahead of print 2 January 2018]","author":"Rabbani","year":"2018","journal-title":"Antioxid Redox Signal"},{"key":"2019060606052398700_bib20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.atherosclerosis.2016.06.048","article-title":"Short-term isocaloric fructose restriction lowers apoC-III levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome","volume":"253","author":"Gugliucci","year":"2016","journal-title":"Atherosclerosis"},{"issue":"2","key":"2019060606052398700_bib21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/oby.21371","article-title":"Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome","volume":"24","author":"Lustig","year":"2016","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"2019060606052398700_bib22","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1053\/j.gastro.2017.05.043","article-title":"Effects of dietary fructose restriction on liver fat, de novo lipogenesis, and insulin kinetics in children with obesity","volume":"153","author":"Schwarz","year":"2017","journal-title":"Gastroenterology"},{"issue":"7","key":"2019060606052398700_bib23","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"2019060606052398700_bib24","volume-title":"Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids","year":"2005"},{"issue":"9","key":"2019060606052398700_bib25","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"issue":"4","key":"2019060606052398700_bib26","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10719-016-9692-0","article-title":"Dicarbonyl stress in clinical obesity","volume":"33","author":"Masania","year":"2016","journal-title":"Glycoconj J"},{"issue":"7","key":"2019060606052398700_bib27","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1515\/cclm-2017-0733","article-title":"Higher D-lactate levels are associated with higher prevalence of small dense low-density lipoprotein in obese adolescents","volume":"56","author":"Rodr\u00edguez-Mortera","year":"2018","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"2019060606052398700_bib28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0003-2697(05)80004-1","article-title":"Fluorimetric assay of D-lactate","volume":"206","author":"McLellan","year":"1992","journal-title":"Anal Biochem"},{"issue":"2","key":"2019060606052398700_bib29","doi-asserted-by":"crossref","first-page":"E227","DOI":"10.1152\/ajpendo.90245.2008","article-title":"Regulation of the fructose transporter GLUT5 in health and disease","volume":"295","author":"Douard","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1-3","key":"2019060606052398700_bib30","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.cbi.2008.10.011","article-title":"Fructose and carbonyl metabolites as endogenous toxins","volume":"178","author":"Lee","year":"2009","journal-title":"Chem Biol Interact"},{"issue":"10","key":"2019060606052398700_bib31","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1194\/jlr.M900022-JLR200","article-title":"Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis","volume":"50","author":"Pickens","year":"2009","journal-title":"J Lipid Res"},{"issue":"1","key":"2019060606052398700_bib32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2337\/diabetes.48.1.198","article-title":"Metformin reduces systemic methylglyoxal levels in type 2 diabetes","volume":"48","author":"Beisswenger","year":"1999","journal-title":"Diabetes"},{"issue":"1","key":"2019060606052398700_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/cs0870021","article-title":"Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications","volume":"87","author":"McLellan","year":"1994","journal-title":"Clin Sci (Lond)"},{"key":"2019060606052398700_bib34","doi-asserted-by":"crossref","first-page":"234812","DOI":"10.1155\/2012\/234812","article-title":"L(+) and D(-) lactate are increased in plasma and urine samples of type 2 diabetes as measured by a simultaneous quantification of L(+) and D(-) lactate by reversed-phase liquid chromatography tandem mass spectrometry","volume":"2012","author":"Scheijen","year":"2012","journal-title":"Exp Diabetes Res"},{"key":"2019060606052398700_bib35","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3389\/fimmu.2017.01159","article-title":"fructose: a dietary sugar in crosstalk with microbiota contributing to the development and progression of non-alcoholic liver disease","volume":"8","author":"Lambertz","year":"2017","journal-title":"Front Immunol"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/7\/3003\/28771435\/jc.2018-02772.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T06:07:01Z","timestamp":1559801221000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/104\/7\/3003\/5376630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,14]]},"references-count":35,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,3,14]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2018-02772","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2019,3,14]]}}}